BEGIN:VCALENDAR VERSION:2.0 PRODID:-//hacksw/handcal//NONSGML v1.0//EN BEGIN:VEVENT UID:b280780445d2fbec64985bc02ac4d289 DTSTAMP:20260517T150219Z DTSTART:20241014T090000 DTEND:20241014T103000 SUMMARY:WHS event – Breaking Boundaries: The Promise of Innovation in AMR DESCRIPTION:\nOct. 14, 2024, CEST: 09:00 AM - 10:30 AM / UTC: 07:00 AM - 08:30 AM\n\n \nDigital Session: https://www.youtube.com/watch?v=FufPGCyOEF4\n \n\nWorkshop (WS 10) - South America\nAntibiotics play a crucial role in modern medicine and without them many treatments and procedures (for example in cancer care, organ transplantation and childbirth) carry a significantly higher risk of complication or failure. However, the increasing resistance of bacterial pathogens to antibiotics - Antimicrobial Resistance (AMR) - undermines the efficacy of these treatments and jeopardizes the benefits of modern healthcare, posing grave risks to vulnerable patient groups.\n\nThe world urgently needs Research & Development (R&D) to develop novel and innovative antibiotics that would not only safeguard the advance of medicine, but further provide value by decreasing the selection pressure on established antibiotics.\n\nWe stand at a pivotal moment to address the pressing health, economic, and societal issues of AMR. Public and private partners are facing the triple challenge of AMR: fostering innovation and viable markets for new, life-saving treatments and diagnostics, ensuring equitable access to safe and effective antibiotics, and the need for stewardship in use. Investment in science, technology, engineering and mathematics (STEM) education will be critical to build the AMR R&D workforce for the future.\n\nAcknowledging that innovation is essential to addressing AMR, and drawing on the anticipated discussions related to the Political Declaration on AMR this session aims to explore real-world solutions in policy, funding and cross-sector collaboration to accelerate the discovery and global supply of groundbreaking antibiotics.\n \n\nHosts:\nGlobal AMR R&D Hub\nRoche\n\n\nModerators:\n\nShiulie Ghosh\nJournalist and TV Anchor | United Kingdom\n \n\n\n\n\nSpeakers:\n\nDr. Khaled Abdel-Ghaffar\nDeputy Prime Minister for Human Development and Minister of Health and Population | Egypt\n \n \n\n\nDr. Cary Adams\nUnion for International Cancer Control (UICC) | CEO | Switzerland\n \n \n\n\nProf. Dr. Sabiha Essack\nUniversity of Kwazulu-Natal | South African Research Chair in Antibiotic Resistance & One Health | South Africa\n \n \n\n\nDr. Malin Grape\nMinistry of Health and Social Affairs | Ambassador on Antimicrobial Resistance | Sweden\n \n \n\n\nDr. Michael Lobritz\nRoche Pharma Research & Early Development (pRED) | Infectious Diseases Therapeutic Area | VP and Global Head | Switzerland\n \n \n\n\nDr. Elmar Nimmesgern\nEuropean Commission | DG Research & Innovation | Policy Officer\n \n \n\n\nDr. Lesley Ogilvie\nGlobal AMR R&D Hub | Secretariat | Director | Germany\n\n\n X-ALT-DESC;FMTTYPE=text/html:\n\n\n\n\n\n\n\n\n

Oct. 14, 2024, CEST: 09:00 AM - 10:30 AM / UTC: 07:00 AM - 08:30 AM



 


Digital Session: https://www.youtube.com/watch?v=FufPGCyOEF4


 



Workshop (WS 10) - South America


Antibiotics play a crucial role in modern medicine and without them many treatments and procedures (for example in cancer care, organ transplantation and childbirth) carry a significantly higher risk of complication or failure. However, the increasing resistance of bacterial pathogens to antibiotics - Antimicrobial Resistance (AMR) - undermines the efficacy of these treatments and jeopardizes the benefits of modern healthcare, posing grave risks to vulnerable patient groups.

The world urgently needs Research & Development (R&D) to develop novel and innovative antibiotics that would not only safeguard the advance of medicine, but further provide value by decreasing the selection pressure on established antibiotics.

We stand at a pivotal moment to address the pressing health, economic, and societal issues of AMR. Public and private partners are facing the triple challenge of AMR: fostering innovation and viable markets for new, life-saving treatments and diagnostics, ensuring equitable access to safe and effective antibiotics, and the need for stewardship in use. Investment in science, technology, engineering and mathematics (STEM) education will be critical to build the AMR R&D workforce for the future.

Acknowledging that innovation is essential to addressing AMR, and drawing on the anticipated discussions related to the Political Declaration on AMR this session aims to explore real-world solutions in policy, funding and cross-sector collaboration to accelerate the discovery and global supply of groundbreaking antibiotics.


 



Hosts:


Global AMR R&D Hub

Roche



Moderators:



Shiulie Ghosh

Journalist and TV Anchor | United Kingdom


 






Speakers:

Dr. Khaled Abdel-Ghaffar

Deputy Prime Minister for Human Development and Minister of Health and Population | Egypt


 


 




Dr. Cary Adams

Union for International Cancer Control (UICC) | CEO | Switzerland


 


 




Prof. Dr. Sabiha Essack

University of Kwazulu-Natal | South African Research Chair in Antibiotic Resistance & One Health | South Africa


 


 




Dr. Malin Grape

Ministry of Health and Social Affairs | Ambassador on Antimicrobial Resistance | Sweden


 


 




Dr. Michael Lobritz

Roche Pharma Research & Early Development (pRED) | Infectious Diseases Therapeutic Area | VP and Global Head | Switzerland


 


 




Dr. Elmar Nimmesgern

European Commission | DG Research & Innovation | Policy Officer


 


 




Dr. Lesley Ogilvie

Global AMR R&D Hub | Secretariat | Director | Germany




\n\n\n LOCATION: END:VEVENT END:VCALENDAR